Dazzling Tecfidera makes its Indian debut
This article was originally published in Scrip
Executive Summary
Biogen Idec has announced launch plans in India for Tecfidera (dimethyl fumarate) – the first oral therapy for remitting multiple sclerosis (RRMS) in the country.